nature.com search

Loading Filters

Showing 1–43 of 43 results

Loading Filters

Amendments and Corrections | 3 March 2020
Correction: Role of growth arrest-specific gene 6-mer axis in multiple myeloma
- J. S. Waizenegger
- , I. Ben-Batalla
- , N. Weinhold
- , T. Meissner
- , M. Wroblewski
- , M. Janning
- , K. Riecken
- , M. Binder
- , D. Atanackovic
- , H. Taipaleenmaeki
- , D. Schewe
- , S. Sawall
- , V. Gensch
- , M. Cubas-Cordova
- , A. Seckinger
- , W. Fiedler
- , E. Hesse
- , N. Kröger
- , B. Fehse
- , D. Hose
- , B. Klein
- , M. S. Raab
- , K. Pantel
- , C. Bokemeyer
- & S. Loges
Leukemia 34 , 2542–2542

Rights & permissionsfor article Correction: Role of growth arrest-specific gene 6-mer axis in multiple myeloma . Opens in a new window.
Amendments and Corrections | 8 October 2015
Erratum: Treatment of multifocal breast cancer by systemic delivery of dual-targeted adeno-associated viral vectors
- M Trepel
- , J Körbelin
- , E Spies
- , M B Heckmann
- , A Hunger
- , B Fehse
- , H A Katus
- , J A Kleinschmidt
- , O J Müller
- & S Michelfelder
Gene Therapy 22 , 848–848

Rights & permissionsfor article Erratum: Treatment of multifocal breast cancer by systemic delivery of dual-targeted adeno-associated viral vectors . Opens in a new window.
Research | 17 July 2017
Impact of molecular residual disease post allografting in myelofibrosis patients
- C Wolschke
- , A Badbaran
- , T Zabelina
- , M Christopeit
- , F Ayuk
- , I Triviai
- , A Zander
- , H Alchalby
- , U Bacher
- , B Fehse
- & N Kröger
Bone Marrow Transplantation 52 , 1526–1529

Rights & permissionsfor article Impact of molecular residual disease post allografting in myelofibrosis patients . Opens in a new window.
Research | 16 November 2017
SHIP1, but not an AML-derived SHIP1 mutant, suppresses myeloid leukemia growth in a xenotransplantation mouse model
- M Täger
- , S Horn
- , E Latuske
- , P Ehm
- , M Schaks
- , M Nalaskowski
- , B Fehse
- , W Fiedler
- , C Stocking
- , J Wellbrock
- & M Jücker
Gene Therapy 24 , 749–753

Rights & permissionsfor article SHIP1, but not an AML-derived SHIP1 mutant, suppresses myeloid leukemia growth in a xenotransplantation mouse model . Opens in a new window.
15 February 2016
Digital-PCR assay for screening and quantitative monitoring of calreticulin (CALR) type-2 positive patients with myelofibrosis following allogeneic stem cell transplantation
- A Badbaran
- , B Fehse
- , M Christopeit
- , T Aranyossy
- , F A Ayuk
- , C Wolschke
- & N Kröger
Bone Marrow Transplantation 51 , 872–873

Rights & permissionsfor article Digital-PCR assay for screening and quantitative monitoring of calreticulin (CALR) type-2 positive patients with myelofibrosis following allogeneic stem cell transplantation . Opens in a new window.
23 May 2016
Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis
- M Christopeit
- , A Badbaran
- , T Zabelina
- , G Zeck
- , B Fehse
- , F Ayuk
- , C Wolschke
- & N Kröger
Bone Marrow Transplantation 51 , 1391–1393

Rights & permissionsfor article Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis . Opens in a new window.
21 May 2014
Low frequency of calreticulin mutations in MDS patients
- M Heuser
- , V Panagiota
- , C Koenecke
- , B Fehse
- , H Alchalby
- , A Badbaran
- , R Shahswar
- , M Stadler
- , M Eder
- , G Göhring
- , A Trummer
- , T Schroeder
- , G Kobbe
- , C Thiede
- , U Platzbecker
- , B Schlegelberger
- , N Kroeger
- , A Ganser
- & F Thol
Leukemia 28 , 1933–1934

Rights & permissionsfor article Low frequency of calreticulin mutations in MDS patients . Opens in a new window.
Research | 2 June 2015
Treatment of multifocal breast cancer by systemic delivery of dual-targeted adeno-associated viral vectors
- M Trepel
- , J Körbelin
- , E Spies
- , M B Heckmann
- , A Hunger
- , B Fehse
- , H A Katus
- , J A Kleinschmidt
- , O J Müller
- & S Michelfelder
Gene Therapy 22 , 840–847

Rights & permissionsfor article Treatment of multifocal breast cancer by systemic delivery of dual-targeted adeno-associated viral vectors . Opens in a new window.
7 February 2014
Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation
- V Panagiota
- , F Thol
- , B Markus
- , B Fehse
- , H Alchalby
- , A Badbaran
- , U Lehmann
- , C Koenecke
- , R Shahswar
- , A Chaturvedi
- , M Stadler
- , M Eder
- , G Göhring
- , M Koenigsmann
- , A Kloos
- , A Trummer
- , T Schroeder
- , G Kobbe
- , C Thiede
- , U Platzbecker
- , B Schlegelberger
- , H-H Kreipe
- , A Ganser
- , N Kröger
- & M Heuser
Leukemia 28 , 1552–1555

Rights & permissionsfor article Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation . Opens in a new window.
22 June 2015
Donor choice in haploidentical stem cell transplantation: fetal microchimerism is associated with better outcome in pediatric leukemia patients
- A Kruchen
- , T Stahl
- , F Gieseke
- , T M C Binder
- , Z Özcan
- , R Meisel
- , H Kreyenberg
- , P Bader
- , B Gruhn
- , J Greil
- , M Pfeiffer
- , M Döring
- , R Handgretinger
- , B Fehse
- & I Müller
Bone Marrow Transplantation 50 , 1367–1370

Rights & permissionsfor article Donor choice in haploidentical stem cell transplantation: fetal microchimerism is associated with better outcome in pediatric leukemia patients . Opens in a new window.
9 May 2014 | Open
Cancer-testis antigen MAGE-C2/CT10 induces spontaneous CD4⁺ and CD8⁺ T-cell responses in multiple myeloma patients
- H Reinhard
- , S Yousef
- , T Luetkens
- , B Fehse
- , B Berdien
- , N Kröger
- & D Atanackovic
Blood Cancer Journal 4 , e212–e212

Rights & permissionsfor article Cancer-testis antigen MAGE-C2/CT10 induces spontaneous CD4<sup>+</sup> and CD8<sup>+</sup> T-cell responses in multiple myeloma patients . Opens in a new window.
Research | 11 May 2009
Influence of mannose-binding lectin genotypes and serostatus in allo-SCT: analysis of 131 recipients and donors
- O W Neth
- , U Bacher
- , P Das
- , T Zabelina
- , H Kabisch
- , N Kroeger
- , F Ayuk
- , M Lioznov
- , O Waschke
- , B Fehse
- , R Thiébaut
- , R M Haston
- , N Klein
- & A R Zander
Bone Marrow Transplantation 45 , 13–19

Rights & permissionsfor article Influence of mannose-binding lectin genotypes and serostatus in allo-SCT: analysis of 131 recipients and donors . Opens in a new window.
9 August 1999
Bicistronic retroviral vectors for combining myeloprotection with cell-surface marking
- M Hildinger
- , A Schilz
- , H-G Eckert
- , W Bohn
- , B Fehse
- , A R Zander
- , W Ostertag
- & C Baum
Gene Therapy 6 , 1222–1230

Rights & permissionsfor article Bicistronic retroviral vectors for combining myeloprotection with cell-surface marking . Opens in a new window.
11 February 2008
Monitoring of minimal residual disease in multiple myeloma after allo-SCT: flow cytometry vs PCR-based techniques
- M Lioznov
- , A Badbaran
- , B Fehse
- , U Bacher
- , A R Zander
- & N M Kröger
Bone Marrow Transplantation 41 , 913–916

Rights & permissionsfor article Monitoring of minimal residual disease in multiple myeloma after allo-SCT: flow cytometry vs PCR-based techniques . Opens in a new window.
Research | 1 February 2007
Gene transfer of SHIP-1 inhibits proliferation of juvenile myelomonocytic leukemia cells carrying KRAS2 or PTPN11 mutations
- A Metzner
- , M A Horstmann
- , B Fehse
- , G Ortmeyer
- , C M Niemeyer
- , C Stocking
- , G W Mayr
- & M Jücker
Gene Therapy 14 , 699–703

Rights & permissionsfor article Gene transfer of <i>SHIP-1</i> inhibits proliferation of juvenile myelomonocytic leukemia cells carrying <i>KRAS2</i> or <i>PTPN11</i> mutations . Opens in a new window.
Research | 1 May 2000
Depletion of alloreactive donor T cells using immunomagnetic cell selection
- B Fehse
- , M Goldmann
- , O Frerk
- , M Bulduk
- & AR Zander
Bone Marrow Transplantation 25 , S39–S42

Rights & permissionsfor article Depletion of alloreactive donor T cells using immunomagnetic cell selection . Opens in a new window.
Research | 25 March 1998
Purging and haemopoietic progenitor cell selection by CD34⁺ cell separation
- W Krüger
- , M Gruber
- , S Hennings
- , N Fehse
- , B Fehse
- , K Gutensohn
- , N Kröger
- & AR Zander
Bone Marrow Transplantation 21 , 665–671

Rights & permissionsfor article Purging and haemopoietic progenitor cell selection by CD34<sup>+</sup> cell separation . Opens in a new window.
Research | 1 May 2000
Amphotropic and VSV-G-pseudotyped retroviral vectors transduce human hematopoietic progenitor cells with similar efficiency
- D von Laer
- , A Corovic
- , B Vogt
- , U Herwig
- , S Roscher
- , B Fehse
- & C Baum
Bone Marrow Transplantation 25 , S75–S79

Rights & permissionsfor article Amphotropic and VSV-G-pseudotyped retroviral vectors transduce human hematopoietic progenitor cells with similar efficiency . Opens in a new window.
Research | 8 November 2002
A novel ‘sort-suicide’ fusion gene vector for T cell manipulation
- B Fehse
- , O S Kustikova
- , Z Li
- , A Wahlers
- , W Bohn
- , W R Beyer
- , D Chalmers
- , P Tiberghien
- , K Kühlcke
- , A R Zander
- & C Baum
Gene Therapy 9 , 1633–1638

Rights & permissionsfor article A novel ‘sort-suicide’ fusion gene vector for T cell manipulation . Opens in a new window.
Research | 1 May 2000
Retroviral transduction of T lymphocytes for suicide gene therapy in allogeneic stem cell transplantation
- K Kühlcke
- , FA Ayuk
- , Z Li
- , C Lindemann
- , A Schilz
- , UM Schade
- , AA Fauser
- , AR Zander
- , H-G Eckert
- & B Fehse
Bone Marrow Transplantation 25 , S96–S98

Rights & permissionsfor article Retroviral transduction of T lymphocytes for suicide gene therapy in allogeneic stem cell transplantation . Opens in a new window.
Research | 6 October 1999
Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirements
- F A Ayuk
- , Z Li
- , K Kühlcke
- , C Lindemann
- , U M Schade
- , H-G Eckert
- , A R Zander
- & B Fehse
Gene Therapy 6 , 1788–1792

Rights & permissionsfor article Establishment of an optimised gene transfer protocol for human primary T lymphocytes according to clinical requirements . Opens in a new window.
Research | 19 June 2006
Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functions
- F A Giordano
- , B Fehse
- , A Hotz-Wagenblatt
- , S Jonnakuty
- , C del Val
- , J-U Appelt
- , K Z Nagy
- , K Kuehlcke
- , S Naundorf
- , A R Zander
- , W J Zeller
- , A D Ho
- , S Fruehauf
- & S Laufs
Bone Marrow Transplantation 38 , 229–235

Rights & permissionsfor article Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functions . Opens in a new window.
Research | 11 January 2010
Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT
- H Alchalby
- , A Badbaran
- , O Bock
- , B Fehse
- , U Bacher
- , A R Zander
- & N Kröger
Bone Marrow Transplantation 45 , 1404–1407

Rights & permissionsfor article Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT . Opens in a new window.
Research | 6 July 2009
Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44⁺) and T (HLA-DR⁺) cells
- M Lioznov
- , J El-Cheikh Jr
- , F Hoffmann
- , Y Hildebrandt
- , F Ayuk
- , C Wolschke
- , D Atanackovic
- , G Schilling
- , A Badbaran
- , U Bacher
- , B Fehse
- , A R Zander
- , D Blaise
- , M Mohty
- & N Kröger
Bone Marrow Transplantation 45 , 349–353

Rights & permissionsfor article Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44<sup>+</sup>) and T (HLA-DR<sup>+</sup>) cells . Opens in a new window.
1 April 2004
Pois(s)on – It's a Question of Dose…
- B Fehse
- , O S Kustikova
- , M Bubenheim
- & C Baum
Gene Therapy 11 , 879–881

Rights & permissionsfor article Pois(s)on – It's a Question of Dose… . Opens in a new window.
Research | 7 April 2008
Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM
- M Lioznov
- , C Dellbrügger
- , A Sputtek
- , B Fehse
- , N Kröger
- & A R Zander
Bone Marrow Transplantation 42 , 121–128

Rights & permissionsfor article Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM . Opens in a new window.
Editorial | 30 April 1998
Impact of a new generation of gene transfer markers on gene therapy
- B Fehse
- , Z Li
- , UM Schade
- , A Uhde
- & AR Zander
Gene Therapy 5 , 429–430

Rights & permissionsfor article Impact of a new generation of gene transfer markers on gene therapy . Opens in a new window.
Research | 14 March 2005
Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants
- M V Lioznov
- , P Freiberger
- , N Kröger
- , A R Zander
- & B Fehse
Bone Marrow Transplantation 35 , 909–914

Rights & permissionsfor article Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants . Opens in a new window.
Correspondence | 28 April 2000
Loss of CD38 antigen on CD34⁺CD38⁺ cells during short-term culture
- D von Laer
- , A Corovic
- , B Vogt
- , B Fehse
- , S Roscher
- , A Rimek
- , C Baum
- & W Ostertag
Leukemia 14 , 947–948

Rights & permissionsfor article Loss of CD38 antigen on CD34<sup>+</sup>CD38<sup>+</sup> cells during short-term culture . Opens in a new window.
Research | 15 January 2009
Reduced proliferation of CD34⁺ cells from patients with acute myeloid leukemia after gene transfer of INPP5D
- A Metzner
- , C Precht
- , B Fehse
- , W Fiedler
- , C Stocking
- , A Günther
- , G W Mayr
- & M Jücker
Gene Therapy 16 , 570–573

Rights & permissionsfor article Reduced proliferation of CD34<sup>+</sup> cells from patients with acute myeloid leukemia after gene transfer of <i>INPP5D</i> . Opens in a new window.
Research | 31 October 2005
Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up
- A A Oyekunle
- , N Kröger
- , T Zabelina
- , F Ayuk
- , H Schieder
- , H Renges
- , N Fehse
- , O Waschke
- , B Fehse
- , H Kabisch
- & A R Zander
Bone Marrow Transplantation 37 , 45–50

Rights & permissionsfor article Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up . Opens in a new window.
27 March 2014
TALEN-mediated editing of endogenous T-cell receptors facilitates efficient reprogramming of T lymphocytes by lentiviral gene transfer
- B Berdien
- , U Mock
- , D Atanackovic
- & B Fehse
Gene Therapy 21 , 539–548

Rights & permissionsfor article TALEN-mediated editing of endogenous T-cell receptors facilitates efficient reprogramming of T lymphocytes by lentiviral gene transfer . Opens in a new window.
Research | 8 August 2014
Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma
- J S Waizenegger
- , I Ben-Batalla
- , N Weinhold
- , T Meissner
- , M Wroblewski
- , M Janning
- , K Riecken
- , M Binder
- , D Atanackovic
- , H Taipaleenmaeki
- , D Schewe
- , S Sawall
- , V Gensch
- , M Cubas-Cordova
- , A Seckinger
- , W Fiedler
- , E Hesse
- , N Kröger
- , B Fehse
- , D Hose
- , B Klein
- , M S Raab
- , K Pantel
- , C Bokemeyer
- & S Loges
Leukemia 29 , 696–704

Rights & permissionsfor article Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma . Opens in a new window.
Research | 13 January 2014
Retroviral insertional mutagenesis in telomerase-immortalized hepatocytes identifies RIPK4 as novel tumor suppressor in human hepatocarcinogenesis
- D Heim
- , K Cornils
- , K Schulze
- , B Fehse
- , A W Lohse
- , T H Brümmendorf
- & H Wege
Oncogene 34 , 364–372

Rights & permissionsfor article Retroviral insertional mutagenesis in telomerase-immortalized hepatocytes identifies RIPK4 as novel tumor suppressor in human hepatocarcinogenesis . Opens in a new window.
Research | 2 August 2007
Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, ΔTrkA
- J Meyer
- , M Rhein
- , B Schiedlmeier
- , O Kustikova
- , C Rudolph
- , K Kamino
- , T Neumann
- , M Yang
- , A Wahlers
- , B Fehse
- , G W Reuther
- , B Schlegelberger
- , A Ganser
- , C Baum
- & Z Li
Leukemia 21 , 2171–2180

Rights & permissionsfor article Remarkable leukemogenic potency and quality of a constitutively active neurotrophin receptor, ΔTrkA . Opens in a new window.
Research | 17 December 2009
Lentiviral gene ontology (LeGO) vectors equipped with novel drug-selectable fluorescent proteins: new building blocks for cell marking and multi-gene analysis
- K Weber
- , U Mock
- , B Petrowitz
- , U Bartsch
- & B Fehse
Gene Therapy 17 , 511–520

Rights & permissionsfor article Lentiviral gene ontology (LeGO) vectors equipped with novel drug-selectable fluorescent proteins: new building blocks for cell marking and multi-gene analysis . Opens in a new window.
23 January 2001
The inositol 5-phosphatase SHIP is expressed as 145 and 135 kDa proteins in blood and bone marrow cells in vivo, whereas carboxyl-truncated forms of SHIP are generated by proteolytic cleavage in vitro
- S Horn
- , J Meyer
- , J Heukeshoven
- , B Fehse
- , C Schulze
- , S Li
- , J Frey
- , S Poll
- , C Stocking
- & M Jücker
Leukemia 15 , 112–120

Rights & permissionsfor article The inositol 5-phosphatase SHIP is expressed as 145 and 135 kDa proteins in blood and bone marrow cells <i>in vivo</i>, whereas carboxyl-truncated forms of SHIP are generated by proteolytic cleavage <i>in vitro</i> . Opens in a new window.
16 September 2004
Self-inactivating retroviral vectors with improved RNA processing
- J Kraunus
- , DHS Schaumann
- , J Meyer
- , U Modlich
- , B Fehse
- , G Brandenburg
- , D von Laer
- , H Klump
- , A Schambach
- , J Bohne
- & C Baum
Gene Therapy 11 , 1568–1578

Rights & permissionsfor article Self-inactivating retroviral vectors with improved RNA processing . Opens in a new window.
30 August 2002
Persisting multilineage transgene expression in the clonal progeny of a hematopoietic stem cell
- Z Li
- , B Fehse
- , B Schiedlmeier
- , J Düllmann
- , O Frank
- , AR Zander
- , W Ostertag
- & C Baum
Leukemia 16 , 1655–1663

Rights & permissionsfor article Persisting multilineage transgene expression in the clonal progeny of a hematopoietic stem cell . Opens in a new window.
Research | 15 December 2011 | Open
Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells
- M Michaelis
- , F Rothweiler
- , S Barth
- , J Cinatl
- , M van Rikxoort
- , N Löschmann
- , Y Voges
- , R Breitling
- , A von Deimling
- , F Rödel
- , K Weber
- , B Fehse
- , E Mack
- , T Stiewe
- , H W Doerr
- , D Speidel
- & J Cinatl jr
Cell Death & Disease 2 , e243–e243

Rights & permissionsfor article Adaptation of cancer cells from different entities to the MDM2 inhibitor nutlin-3 results in the emergence of p53-mutated multi-drug-resistant cancer cells . Opens in a new window.
30 June 2008
Minimal residual disease diagnostics in myeloid malignancies in the post transplant period
- U Bacher
- , A R Zander
- , T Haferlach
- , S Schnittger
- , B Fehse
- & N Kröger
Bone Marrow Transplantation 42 , 145–157

Rights & permissionsfor article Minimal residual disease diagnostics in myeloid malignancies in the post transplant period . Opens in a new window.
1 November 2007
Insertional mutagenesis and clonal dominance: biological and statistical considerations
- B Fehse
- & I Roeder
Gene Therapy 15 , 143–153

Rights & permissionsfor article Insertional mutagenesis and clonal dominance: biological and statistical considerations . Opens in a new window.
30 September 2004
Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3β signaling and leads to an increased transit time through the G1 phase of the cell cycle
- S Horn
- , E Endl
- , B Fehse
- , M M Weck
- , G W Mayr
- & M Jücker
Leukemia 18 , 1839–1849

Rights & permissionsfor article Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3<i>β</i> signaling and leads to an increased transit time through the G1 phase of the cell cycle . Opens in a new window.

Quick links